Chemotherapeutic activity of 6-methoxy-1-phenazinol 5,10-dioxide, cupric complex in experimentally induced local microbial infections of dogs.
D000818:Animals; D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D002176:Candida albicans; D003300:Copper / Q000627:therapeutic use*; D003497:Cyclic N-Oxides / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy / Q000662:veterinary; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005128:Eye Diseases / Q000188:drug therapy / Q000662:veterinary; D005260:Female; D007239:Infections / Q000662:veterinary*; D008297:Male; D008864:Microsporum; D003904:Mitosporic Fungi; D010031:Otitis / Q000188:drug therapy / Q000662:veterinary; D010619:Phenazines / Q000627:therapeutic use*; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000662:veterinary
D000900:Anti-Bacterial Agents; D000891:Anti-Infective Agents, Local; D003497:Cyclic N-Oxides; D010619:Phenazines; D003300:Copper